title: Frequency of thiopurine S-methyltransferase mutant alleles in indigenous and admixed Guatemalan patients with acute lymphoblastic leukemia.
abstract: Thiopurine S-methyltransferase (TPMT) polymorphisms affect the enzyme's activity and are predictive for the efficacy and toxicity of thiopurine treatment of acute lymphoblastic leukemia (ALL), autoimmune diseases and organ transplants. Because inter-ethnic differences in the distribution of these polymorphisms have been documented, we sequenced the TMPT gene in 95 Guatemalans, yet identified no new alleles. We also determined the frequency of the TPMT 2, 3A, 3B and 3C alleles in 270 admixed and 177 indigenous pediatric patients with ALL and healthy subjects from Guatemala using TaqMan assays and DNA sequencing. Among the 447 subjects genotyped, 10.0 % of the ALL cases and 13.6 % of the healthy controls were heterozygous for one of the four TPMT variants screened. The genotype frequencies in ALL and control populations were 0.7 and 1.7 % for TPMT 1/ 2, 7.4 and 10 % for TPMT 1/3A, 0.3 and 0 % for TPMT 1/B, and 1.5 and 1.1 % for TPMT 1/C, respectively (p = 0.30). No statistically significant differences between admixed and indigenous ALL (p = 0.67) or controls (p = 0.41) groups were detected; however, 17 % of the admixed healthy group bore one TPMT mutant allele, and they have one of the highest reported frequencies of TPMT mutant allele carriers. Because of the clinical implications of these variants for therapeutic response, TPMT allele testing should be considered in all Guatemalan patients to reduce adverse side-effects from thiopurine drug treatments.
authors: Unidad Nacional de Oncología Pediátrica, Guatemala City, Guatemala.
authors: Claudia
authors: C
authors: Garrido
authors: Veronica Giron
authors: VG
authors: Santizo
authors: Petra
authors: P
authors: Müllers
authors: Daphney Rigaud
authors: DR
authors: Soriano
authors: Giovana Bendfeldt
authors: GB
authors: Avila
authors: Michael
authors: M
authors: Dean
authors: Silvia
authors: S
authors: Jimenez-Morales
mesh_terms: D000328:Adult; D000483:Alleles; D002648:Child; D005260:Female; D005838:Genotype; D006166:Guatemala; D006801:Humans; D008297:Male; D008780:Methyltransferases / Q000235:genetics*; D009154:Mutation; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000235:genetics*; D020133:Reverse Transcriptase Polymerase Chain Reaction
chemical_list: D008780:Methyltransferases; C022745:thiopurine methyltransferase
references: J Pediatr Hematol Oncol. 2002 Jun-Jul;24(5):353-9
references: 12142782
references: Pediatr Blood Cancer. 2009 Feb;52(2):203-8
references: 19034904
references: J Clin Pharm Ther. 2006 Jun;31(3):283-7
references: 16789994
references: Clin Pharmacol Ther. 2011 Mar;89(3):387-91
references: 21270794
references: Pharmacogenetics. 2004 Jul;14(7):407-17
references: 15226673
references: J Hum Genet. 2007;52(2):129-142
references: 17151812
references: Blood. 2009 Jun 11;113(24):6077-84
references: 19224761
references: Br J Clin Pharmacol. 2009 Nov;68(5):770-2
references: 19917002
references: Eur J Clin Pharmacol. 2010 Oct;66(10):999-1003
references: 20521035
references: Mutat Res. 2000 Mar 14;448(1):91-5
references: 10751626
references: Genet Test Mol Biomarkers. 2011 May;15(5):351-5
references: 21254844
references: Rev Med Chil. 2009 Feb;137(2):185-92
references: 19543639
references: Curr Pharm Des. 2010;16(2):145-54
references: 20205660
references: Clin Ther. 2009 Jul;31(7):1524-33
references: 19695401
references: Med Oncol. 2008;25(1):56-62
references: 18188716
references: Pharmacology. 2006;77(3):105-14
references: 16691038
references: Br J Clin Pharmacol. 2001 May;51(5):475-7
references: 11422006
references: Pharmacogenet Genomics. 2008 May;18(5):434-8
references: 18408566
references: Hum Mol Genet. 1999 Feb;8(2):371-6
references: 9931346
references: J Clin Pharm Ther. 2006 Feb;31(1):93-8
references: 16476125
references: Pediatr Blood Cancer. 2011 Oct;57(4):578-82
references: 21319286
references: Nat Genet. 2009 Dec;41(12):1345-9
references: 19898482
references: Cancer Res. 2008 Jul 1;68(13):4983-9
references: 18593894
references: Pharmacogenomics. 2009 Nov;10(11):1753-65
references: 19891552
references: Ann Clin Biochem. 2003 Jul;40(Pt 4):388-93
references: 12880540
references: Clin Chem. 2004 Feb;50(2):288-95
references: 14656901
references: Nucleosides Nucleotides Nucleic Acids. 2008 Jun;27(6):835-8
references: 18600549
references: Biochem Pharmacol. 2008 Aug 1;76(3):404-15
references: 18602085
references: J Clin Pharm Ther. 2005 Oct;30(5):491-6
references: 16164497
references: Eur J Clin Pharmacol. 2008 Aug;64(8):753-67
references: 18506437
references: Proc Natl Acad Sci U S A. 1997 Jun 10;94(12):6444-9
references: 9177237
references: Pharmacogenet Genomics. 2007 Oct;17(10):891-5
references: 17885628
references: Nucleosides Nucleotides Nucleic Acids. 2010 Mar;29(3):237-44
references: 20408054
references: Tissue Antigens. 2003 Jun;61(6):425-36
references: 12823766
references: Pharmacogenomics J. 2003;3(3):178-82
references: 12815366
references: Cancer Chemother Pharmacol. 2011 Nov;68(5):1155-9
references: 21400026
references: Eur J Clin Pharmacol. 2004 Apr;60(2):89-96
references: 15022030
references: J Clin Pharm Ther. 2012 Apr;37(2):237-41
references: 21545474
references: Methods Find Exp Clin Pharmacol. 2003 Jul-Aug;25(6):423-9
references: 12949626
references: J Clin Oncol. 2001 Apr 15;19(8):2293-301
references: 11304783
references: Mol Biol Rep. 2012 Apr;39(4):4581-7
references: 21938428
references: Clin Chim Acta. 2006 Mar;365(1-2):337-41
references: 16223474
references: Hum Mol Genet. 1999 Feb;8(2):367-70
references: 9931345
references: J Clin Pharm Ther. 2009 Dec;34(6):703-8
references: 20175804
references: Med Clin (Barc). 2006 Mar 25;126(11):410-2
references: 16595084
references: Pharmacogenomics. 2011 Jan;12(1):113-24
references: 21174626
references: Eur J Clin Pharmacol. 2009 Mar;65(3):257-62
references: 19048244
references: Nat Rev Nephrol. 2011 Jun 28;7(8):478-84
references: 21712851
references: Pharmacogenetics. 1999 Dec;9(6):773-6
references: 10634140
references: Ann Hum Genet. 2004 Jul;68(Pt 4):313-23
references: 15225157
references: Br J Clin Pharmacol. 2003 Jun;55(6):560-9
references: 12814450